DEA Extends Telemedicine Buprenorphine Rules Through 2026
A final rule now permanently allows buprenorphine via telehealth for up to 6 months without an in-person visit.
Body: [News-style article: what the rule changes, what the 6-month window means in practice, why the field had been bracing for a cliff, what clinicians and patients should know, caveats on state-by-state variation, how it affects telehealth-first programs like Bicycle Health and Ophelia. 800 words.]
Sources Cited
- 01.A
Filed Under
DEAMAT — BuprenorphineFederalPolicy
Keep up with the reporting.
One email each morning with the stories that put days like this in context.
Continue reading
More from this section
The DEA Just Registered 900 Dispensaries. Nobody Registered a Plan for the Patient.
DOJ announced federal DEA registration for 900+ medical cannabis dispensaries in seven states, while refusing a Minnesota dual-licensed shop. What the implementation gates mean for providers.
Policy & FundingMarijuana Arrests Rose for the First Time in a Decade, and Almost All of the Increase Was Black
FWD.us reports cannabis possession arrests rose in 2025 for the first time in at least a decade. What the 83% and 45% figures actually measure, and what case managers and treatment intake teams can do with a pending charge.
Policy & FundingThe FDA Says Zyn Is Safer Than a Cigarette. It Left the Hard Part Off the Label.
The FDA's June 2026 modified-risk order lets 20 Zyn pouches claim lower disease risk than cigarettes. It says nothing about dependence, quitting, or the teenagers using the brand most.